NL1013049A1 - Werkwijze ter versterking van de antitumoractiviteit van ruwe geneesmiddelen, preparaat dat een ruw geneesmiddel met versterkte antitumoractiviteit bevat, werkwijze ter beoordeling van de effectiviteit van de behandeling van het ruwe geneesmiddel op de antitumoractiviteit, en werkwijze ter beoordeling van de antitumoractiviteit van een ruw geneesmiddel. - Google Patents

Werkwijze ter versterking van de antitumoractiviteit van ruwe geneesmiddelen, preparaat dat een ruw geneesmiddel met versterkte antitumoractiviteit bevat, werkwijze ter beoordeling van de effectiviteit van de behandeling van het ruwe geneesmiddel op de antitumoractiviteit, en werkwijze ter beoordeling van de antitumoractiviteit van een ruw geneesmiddel.

Info

Publication number
NL1013049A1
NL1013049A1 NL1013049A NL1013049A NL1013049A1 NL 1013049 A1 NL1013049 A1 NL 1013049A1 NL 1013049 A NL1013049 A NL 1013049A NL 1013049 A NL1013049 A NL 1013049A NL 1013049 A1 NL1013049 A1 NL 1013049A1
Authority
NL
Netherlands
Prior art keywords
tumor activity
crude drug
evaluating
crude
effectiveness
Prior art date
Application number
NL1013049A
Other languages
English (en)
Other versions
NL1013049C2 (nl
Inventor
Kozo Niwa
Original Assignee
Kozo Niwa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kozo Niwa filed Critical Kozo Niwa
Publication of NL1013049A1 publication Critical patent/NL1013049A1/nl
Application granted granted Critical
Publication of NL1013049C2 publication Critical patent/NL1013049C2/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material
NL1013049A 1998-09-17 1999-09-15 Werkwijze ter versterking van de antitumoractiviteit van ruwe geneesmiddelen en preparaat dat een ruw geneesmiddel met versterkte antitumoractiviteit bevat. NL1013049C2 (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP26375398 1998-09-17
JP26375398 1998-09-17
JP32337498 1998-11-13
JP10323374A JP2000159682A (ja) 1998-09-17 1998-11-13 生薬の抗腫瘍活性強化方法、抗腫瘍活性強化生薬含有組成物、生薬処理の抗腫瘍有効性評価方法、および生薬の抗腫瘍有効性評価方法

Publications (2)

Publication Number Publication Date
NL1013049A1 true NL1013049A1 (nl) 2000-03-21
NL1013049C2 NL1013049C2 (nl) 2002-01-11

Family

ID=26546176

Family Applications (2)

Application Number Title Priority Date Filing Date
NL1013049A NL1013049C2 (nl) 1998-09-17 1999-09-15 Werkwijze ter versterking van de antitumoractiviteit van ruwe geneesmiddelen en preparaat dat een ruw geneesmiddel met versterkte antitumoractiviteit bevat.
NL1019705A NL1019705C2 (nl) 1998-09-17 2002-01-07 Werkwijze ter beoordeling van de effectiviteit van een behandeling van een ruw geneesmiddel ter versterking van de antitumoractiviteit, en werkwijze ter beoordeling van de antitumoreffectiviteit van een ruw geneesmiddel.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NL1019705A NL1019705C2 (nl) 1998-09-17 2002-01-07 Werkwijze ter beoordeling van de effectiviteit van een behandeling van een ruw geneesmiddel ter versterking van de antitumoractiviteit, en werkwijze ter beoordeling van de antitumoreffectiviteit van een ruw geneesmiddel.

Country Status (19)

Country Link
JP (1) JP2000159682A (nl)
KR (1) KR20000023206A (nl)
CN (1) CN1255376A (nl)
AU (1) AU4486299A (nl)
BE (1) BE1012725A5 (nl)
CA (1) CA2282234A1 (nl)
DE (1) DE19944695A1 (nl)
DK (1) DK199901235A (nl)
ES (1) ES2155802B1 (nl)
FR (2) FR2783426A1 (nl)
GB (2) GB9920710D0 (nl)
ID (1) ID23150A (nl)
IL (1) IL131722A0 (nl)
IS (1) IS5183A (nl)
IT (1) IT1307267B1 (nl)
NL (2) NL1013049C2 (nl)
NO (1) NO994463L (nl)
SE (2) SE9903307L (nl)
SG (1) SG76631A1 (nl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE354355T1 (de) * 2001-04-27 2007-03-15 Ajinomoto Kk Eine dispersion aus beta-glukan enthaltenden hochfeinen partikel, ein entsprechender herstellungsprozess und die verwendung der dispersion
CN1320121C (zh) * 2001-05-07 2007-06-06 拜奥哈步株式会社 制备蘑菇乳酸发酵溶液的方法及由此制备的蘑菇乳酸发酵溶液
JP4499979B2 (ja) * 2001-05-21 2010-07-14 コンビ株式会社 病原菌感染抑制用組成物
JP4561098B2 (ja) * 2001-06-01 2010-10-13 味の素株式会社 糖尿病用薬剤
JP4681801B2 (ja) * 2002-05-15 2011-05-11 ビーエイチエヌ株式会社 血管新生阻害剤およびその製造方法
KR100971599B1 (ko) 2002-05-15 2010-07-20 비에이취엔 가부시끼가이샤 혈관 관련 질환의 예방 또는 치료를 위한 조성물
JP4826696B2 (ja) * 2003-04-07 2011-11-30 ビーエイチエヌ株式会社 血管新生阻害剤
JP2005089417A (ja) * 2003-09-19 2005-04-07 Noevir Co Ltd 糖尿病予防・治療用組成物
JP4587441B2 (ja) * 2004-02-12 2010-11-24 株式会社クレハ 新規な糖尿病治療剤および食品
JP5034071B2 (ja) * 2004-09-17 2012-09-26 株式会社Ｓ・Ｓ・Ｉ 乳癌を抑制するカワリハラタケ抽出物
JP2006273835A (ja) * 2005-03-04 2006-10-12 Michishi Tani 悪性腫瘍治療剤及びそれを含む飲食品
US20120128856A1 (en) * 2009-07-31 2012-05-24 Ming East-West, Llc Maitake mushroom coffee
WO2011081024A1 (ja) * 2009-12-29 2011-07-07 株式会社富士見養蜂園 旨味食品及びその製造方法
CN106333969A (zh) * 2016-08-30 2017-01-18 青海民族大学 圆孢蘑菇抑制hdac1酶有效部位及制法和应用
CN106309511A (zh) * 2016-08-30 2017-01-11 青海民族大学 圆孢蘑菇抑制cdc25酶有效部位及制法和应用
WO2019104579A1 (en) * 2017-11-30 2019-06-06 SHIEH, Darbin Method for predicting and modulating susceptibility of cancer cell to programmed cell death
KR102646421B1 (ko) * 2020-12-16 2024-03-12 대한민국 잎새버섯 생리활성성분 및 영양성분의 함량을 증가시키는 방법
KR102602787B1 (ko) * 2020-12-16 2023-11-17 대한민국 꽃송이버섯 생리활성성분 및 영양성분의 함량을 증가시키는 방법
KR102584680B1 (ko) * 2020-12-17 2023-10-06 대한민국 생리활성 및 영양성분이 증가된 표고버섯차 제조방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5276413A (en) * 1975-12-18 1977-06-27 Kureha Chem Ind Co Ltd Production of oncostatic substances
US4177108A (en) * 1977-03-02 1979-12-04 Tetsuro Ikekawa Process for producing emitanin
DE2842691A1 (de) * 1978-09-30 1980-04-10 Karl Dr Med Theurer Energetische anregung biologischer arzneimittel
JPS57206618A (en) * 1981-06-12 1982-12-18 Noda Shiyokukin Kogyo Kk Preparation of antitumor substance
JPH02203765A (ja) * 1989-02-02 1990-08-13 Nippon Beet Sugar Mfg Co Ltd 抗腫瘍機能を有する食品及びその製造法
JP3357383B2 (ja) * 1991-08-14 2002-12-16 昌宏 黒田 低分子化植物性組成物
JP2955126B2 (ja) * 1992-06-22 1999-10-04 笑代 丹羽 医薬用油性製剤、食品用油性製剤およびそれらの製造方法
US6015913A (en) * 1996-09-06 2000-01-18 Mars, Incorporated Method for producing fat and/or solids from cocoa beans

Also Published As

Publication number Publication date
NO994463D0 (no) 1999-09-15
KR20000023206A (ko) 2000-04-25
NL1013049C2 (nl) 2002-01-11
SG76631A1 (en) 2000-11-21
FR2783426A1 (fr) 2000-03-24
ES2155802A1 (es) 2001-05-16
ITTO990784A1 (it) 2001-03-14
DE19944695A1 (de) 2000-03-30
IL131722A0 (en) 2001-03-19
BE1012725A5 (fr) 2001-02-06
CA2282234A1 (en) 2000-03-17
GB2341800A (en) 2000-03-29
SE0100195D0 (sv) 2001-01-24
GB9920710D0 (en) 1999-11-03
SE0100195L (sv) 2001-01-24
CN1255376A (zh) 2000-06-07
ES2155802B1 (es) 2001-12-01
JP2000159682A (ja) 2000-06-13
NO994463L (no) 2000-03-20
NL1019705A1 (nl) 2002-01-29
IT1307267B1 (it) 2001-10-30
DK199901235A (da) 2000-03-18
IS5183A (is) 2000-03-17
AU4486299A (en) 2000-03-30
ITTO990784A0 (it) 1999-09-14
NL1019705C2 (nl) 2002-03-26
ID23150A (id) 2000-03-23
FR2788697A1 (fr) 2000-07-28
SE9903307D0 (sv) 1999-09-16
SE9903307L (sv) 2000-03-18
GB9921387D0 (en) 1999-11-10

Similar Documents

Publication Publication Date Title
NL1013049A1 (nl) Werkwijze ter versterking van de antitumoractiviteit van ruwe geneesmiddelen, preparaat dat een ruw geneesmiddel met versterkte antitumoractiviteit bevat, werkwijze ter beoordeling van de effectiviteit van de behandeling van het ruwe geneesmiddel op de antitumoractiviteit, en werkwijze ter beoordeling van de antitumoractiviteit van een ruw geneesmiddel.
EE200000522A (et) Fosfolipaas A2 ensüümi inhibiitor, seda sisaldav farmatseutiline kompositsioon ning meetod fosfolipaasensüümi toime pärssimiseks
ATE318138T1 (de) Pharmazeutisches mittel zur behandlung von diabetes
DZ2964A1 (fr) Diphénylurées substituées nouvelles, et compositions pharmaceutiques les contenant.
BR9910744B1 (pt) introdutor de catéter iv com auto-retração.
BR0007067B1 (pt) sistema e mÉtodo de processamento de sangue.
TR199800436A3 (tr) Primidin türevlerinin kanserin önlenmesi için kullanilmasi.
ITSV980070A0 (it) Sistema endovascolare per il trattamento delle stenosi carotidee e catetere per tale sistema.
BR9816196B1 (pt) sistema de produto de cuidado pessoal.
ID28028A (id) Zat-zat farmasi untuk pengobatan penyakit parkinson, adhd dan mikroadenomas
ITRM950533A0 (it) Sistema di costruzione di prodotti di oreficeria e/o gioielleria, progettati in sezioni, settori e porzioni di settori, variamente assemblabili in sequenza.
HK1015789A1 (en) Propanolamine derivatives, processes for their preparation, pharmaceuticals comprising these compounds, and their use.
TR199801871A3 (tr) Bifenilsulfonilsiyanamidler üretim yöntemi ve ilaç olarak kullanimlari.
IL165213A0 (en) Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilizationmedicament or diagnostic agent and medicament containing same
NL1017117A1 (nl) Werkwijze voor de versterking van de antitumoractiviteit van een amygdalinebevattend materiaal, preparaat dat versterkt amygdalinebevattend materiaal bevat, werkwijze ter beoordeling van de antitumoreffectiviteit van een behandeling van amygdalinebevattend materiaal, en werkwijze ter beoordeling van amygdalinebevattend antitumormateriaal.
ATE276234T1 (de) Harnstoffderivate zur schmerzbekämpfung
BR9909024B1 (pt) derivado de piridina, produto farmacêutico contendo o mesmo, composição farmacêutica e seus usos.
ZA9710181B (en) Method and composition for enhancing biocidal activity.
IT1316441B1 (it) Trattamento adesivante di stuoie per pavimenti.
DE29721290U1 (de) Fleischmasse o.dgl.
DZ2159A1 (fr) Produits pharmaceutiques.
MA26677A1 (fr) Medicaments antiparkinsoniens.
NO20012616D0 (no) Middel til behandling av erektil malfunksjon
PT1064014E (pt) Medicamento para o impedimento ou tratamento de tumores especificos de papilomavirus
HUP0104304A3 (en) Pharmaceutical composition with antitumor activity on the basis of carboplatin

Legal Events

Date Code Title Description
AD1A A request for search or an international type search has been filed
RD2N Patents in respect of which a decision has been taken or a report has been made (novelty report)

Effective date: 20010907

PD2B A search report has been drawn up
VD1 Lapsed due to non-payment of the annual fee

Effective date: 20040401